Angiogenesis inhibitors, like bevacizumab, hinder the formation of new blood vessels. They are crucial in cancer treatment, as many tumors rely on angiogenesis to grow and spread. By blocking this process, angiogenesis inhibitors can limit the tumor's blood supply, hindering its ability to thrive.
